Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications
Gray, Steven G., Al-Sarraf, Nael, Baird, Anne-Marie, Cathcart, Mary-Clare, McGovern, Eilish, & O'Byrne, Kenneth J. (2009) Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications. European Journal of Cancer, 45(17), pp. 3087-3097.
Background: Cyclooxygenase (COX)-2 is frequently overexpressed in non-small cell lung cancer (NSCLC) and results in increased levels of prostaglandin E2 (PGE 2), an important signalling molecule implicated in tumourigenesis. PGE 2 exerts its effects through the E prostanoid (EP) receptors (EPs1-4). Methods: The expression and epigenetic regulation of the EPs were evaluated in a series of resected fresh frozen NSCLC tumours and cell lines.
Results: EP expression was dysregulated in NSCLC being up and downregulated compared to matched control samples. For EPs1, 3 and 4 no discernible pattern emerged. EP2 mRNA however was frequently downregulated, with low levels being observed in 13/20 samples as compared to upregulation in 5/20 samples examined. In NSCLC cell lines DNA CpG methylation was found to be important for the regulation of EP3 expression, the demethylating agent decitabine upregulating expression. Histone acetylation was also found to be a critical regulator of EP expression, with the histone deacteylase inhibitors trichostatin A, phenylbutyrate and suberoylanilide hydroxamic acid inducing increased expression of EPs2-4. Direct chromatin remodelling was demonstrated at the promoters for EPs2-4.
Conclusions: These results indicate that EP expression is variably altered from tumour to tumour in NSCLC. EP2 expression appears to be predominantly downregulated and may have an important role in the pathogenesis of the disease. Epigenetic regulation of the EPs may be central to the precise role COX-2 may play in the evolution of individual tumours. © 2009 Elsevier Ltd. All rights reserved.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||Chromatin, Epigenetics, Methylation, Non-small cell lung cancer, Prostanoid, 5 aza 2' deoxycytidine, antineoplastic agent, arylbutyric acid derivative, histone, messenger RNA, prostaglandin E receptor, prostaglandin e receptor 1, prostaglandin E receptor 2, prostaglandin E receptor 3, prostaglandin E receptor 4, trichostatin A, unclassified drug, vorinostat, acetylation, article, cancer cell culture, chromatin assembly and disassembly, controlled study, CpG island, DNA methylation, DNA modification, frozen section, gene expression regulation, human, human cell, human tissue, lung adenocarcinoma, lung non small cell cancer, priority journal, protein expression, receptor down regulation, receptor upregulation, squamous cell carcinoma, Antineoplastic Agents, Azacitidine, Carcinoma, Non-Small-Cell Lung, Cell Proliferation, CpG Islands, Epigenesis, Genetic, Gene Expression Regulation, Neoplastic, Histone Deacetylase Inhibitors, Histones, Humans, Hydroxamic Acids, Lung Neoplasms, Phenylbutyrates, Receptors, Prostaglandin E, RNA, Messenger, Tumor Cells, Cultured|
|Divisions:||Current > Schools > School of Biomedical Sciences
Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
|Copyright Owner:||Copyright 2009 Pergamon|
|Deposited On:||05 Dec 2013 00:45|
|Last Modified:||29 Jul 2014 23:50|
Repository Staff Only: item control page